长风药业：董事会批准有关股份购回授权议案
CF PHARMTECHCF PHARMTECH(HK:02652) Zhi Tong Cai Jing·2025-11-12 23:57

Core Viewpoint - Changfeng Pharmaceutical (02652) has announced that its board has approved a resolution regarding the proposal to grant the directors a general mandate to repurchase the company's issued H shares listed on the Main Board of the Hong Kong Stock Exchange [1] Group 1 - The proposal will be presented to the company's shareholders for consideration and approval at a special general meeting to be held at an appropriate time [1]